Mark R Hennings

Array ( [id] => 1230424 [patent_doc_number] => 06692746 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Tumor killing effects of enterotoxins, superantigens, and related compounds' [patent_app_type] => B1 [patent_app_number] => 09/708008 [patent_app_country] => US [patent_app_date] => 2000-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23152 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692746.pdf [firstpage_image] =>[orig_patent_app_number] => 09708008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790917 [patent_doc_number] => 05780298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'DNA encoding the sn-RNP-A antigen and fragments thereof' [patent_app_type] => 1 [patent_app_number] => 8/959096 [patent_app_country] => US [patent_app_date] => 1997-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 1991 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780298.pdf [firstpage_image] =>[orig_patent_app_number] => 959096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022801 [patent_doc_number] => 05882898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Streptococcus pneumoniae polynucleotides which encode folyl-polyglutamate synthetase (FPGS) polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/934846 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11677 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882898.pdf [firstpage_image] =>[orig_patent_app_number] => 934846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022769 [patent_doc_number] => 05882896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'M protein' [patent_app_type] => 1 [patent_app_number] => 8/929418 [patent_app_country] => US [patent_app_date] => 1997-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11241 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882896.pdf [firstpage_image] =>[orig_patent_app_number] => 929418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963882 [patent_doc_number] => 05885805 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'gbpA' [patent_app_type] => 1 [patent_app_number] => 8/915107 [patent_app_country] => US [patent_app_date] => 1997-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14095 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885805.pdf [firstpage_image] =>[orig_patent_app_number] => 915107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920891 [patent_doc_number] => 05876722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'DNA encoding Derf II, the major mite allergen, host cells containing such DNA and methods for producing Derf II' [patent_app_type] => 1 [patent_app_number] => 8/910075 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3801 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876722.pdf [firstpage_image] =>[orig_patent_app_number] => 910075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871134 [patent_doc_number] => 05837825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Campylobacter jejuni flagellin/Escherichia coli LT-B fusion protein' [patent_app_type] => 1 [patent_app_number] => 8/829026 [patent_app_country] => US [patent_app_date] => 1997-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7142 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837825.pdf [firstpage_image] =>[orig_patent_app_number] => 829026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838276 [patent_doc_number] => 05744353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules' [patent_app_type] => 1 [patent_app_number] => 8/796883 [patent_app_country] => US [patent_app_date] => 1997-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 29 [patent_no_of_words] => 13838 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744353.pdf [firstpage_image] =>[orig_patent_app_number] => 796883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4005837 [patent_doc_number] => 05888810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Campylobacteri jejuni flagellin-escherichia coli LT-B fusion protein' [patent_app_type] => 1 [patent_app_number] => 8/784218 [patent_app_country] => US [patent_app_date] => 1997-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7140 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888810.pdf [firstpage_image] =>[orig_patent_app_number] => 784218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781517 [patent_doc_number] => 05736141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund\'s adjuvant' [patent_app_type] => 1 [patent_app_number] => 8/739812 [patent_app_country] => US [patent_app_date] => 1996-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4665 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736141.pdf [firstpage_image] =>[orig_patent_app_number] => 739812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355607 [patent_doc_number] => 06291639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds' [patent_app_type] => 1 [patent_app_number] => 8/635928 [patent_app_country] => US [patent_app_date] => 1996-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 12532 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291639.pdf [firstpage_image] =>[orig_patent_app_number] => 635928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811094 [patent_doc_number] => 05770208 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Staphylococcus aureus B-linked hexosamine antigen' [patent_app_type] => 1 [patent_app_number] => 8/712438 [patent_app_country] => US [patent_app_date] => 1996-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5205 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770208.pdf [firstpage_image] =>[orig_patent_app_number] => 712438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879717 [patent_doc_number] => 05747653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method of producing of an antimeningococcic hyperimmune gamma globulin and gamma globulin produced by method' [patent_app_type] => 1 [patent_app_number] => 8/692055 [patent_app_country] => US [patent_app_date] => 1996-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6343 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 320 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747653.pdf [firstpage_image] =>[orig_patent_app_number] => 692055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949526 [patent_doc_number] => 05955432 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Metabolic effects of certain glutathione analogs' [patent_app_type] => 1 [patent_app_number] => 8/675095 [patent_app_country] => US [patent_app_date] => 1996-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 33 [patent_no_of_words] => 10372 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955432.pdf [firstpage_image] =>[orig_patent_app_number] => 675095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040969 [patent_doc_number] => 05874251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'DNA encoding the Taenia crassiceps ten kilodalton antigen' [patent_app_type] => 1 [patent_app_number] => 8/648496 [patent_app_country] => US [patent_app_date] => 1996-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7751 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874251.pdf [firstpage_image] =>[orig_patent_app_number] => 648496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824932 [patent_doc_number] => 05783422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'DNA fragment coding for squamous cell carcinoma-associated antigen' [patent_app_type] => 1 [patent_app_number] => 8/568147 [patent_app_country] => US [patent_app_date] => 1995-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7599 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783422.pdf [firstpage_image] =>[orig_patent_app_number] => 568147 [rel_patent_id] =>[rel_patent_doc_number] =>)